(PDF) Persistence With First-Line Biologics Used in

Persistence With First-Line Biologics Used in Rheumatoid Arthritis in a Us Managed Care Population

Value in Health - United Kingdom

doi 10.1016/j.jval.2015.03.972

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

May 1, 2015

Authors

Publisher

Elsevier BV

Related search

Managed Care Strategies for Improving Patient Outcomes in Rheumatoid Arthritis

Journal of Managed Care Pharmacy

English

The Landscape of Pharmacogenetic Testing in a US Managed Care Population

Genetics in Medicine

English

Global Variations in Biologics Access and Rheumatoid Arthritis Treatment Costs

Value in Health

Occupational Health

English

Patients With Rheumatoid Arthritis in Clinical Care

Annals of the Rheumatic Diseases

Molecular Biology

English

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

Value in Health

Occupational Health

English

Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis

Arthritis Care and Research

English

Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the Rheumatic Diseases

Molecular Biology

English

Relative Risk of All-Cause Mortality in Patients With Nontuberculous Mycobacterial Lung Disease in a US Managed Care Population

Respiratory Medicine

Respiratory Medicine

English

Medication Adherence and Persistence in Patients With Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: A Systematic Literature Review

Patient Preference and Adherence

Social Sciences

English